Biomarkers for PTSD
Abstract
It is estimated that 10% to 20% of warfighters who have served in Iraq and Afghanistan have PTSD 1-4. An important limitation of these estimates is the reliance on self-report screening measures and clinical interviews to make the diagnosis of PTSD. These methods are subject to a number of biases, including underreporting of PTSD symptoms because of stigma of mental illness and concerns about adverse effects on careers, and exaggeration of symptoms in those seeking compensation for service- connected disability5. Development of biomarkers of PTSD is critical for DOD and VA as objective indicators of PTSD for use in postdeployment medical screening, treatment selection, treatment outcome monitoring, disability evaluations, and for informing novel targets for treatment development.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2011
- Accession Number
- ADA618638
Entities
People
- Charles Marmar
Organizations
- New York University